Skip to main content
. 2022 Jun 27;31(2):114–122. doi: 10.4274/mirt.galenos.2022.73636

Figure 3.

Figure 3

Boxplots representing significant distributions of median serum VEGF and PDGF levels of patients who had progression on treated liver lobe in the 6th week of follow-up

VEGF: Vascular endothelial growth factor, PDGF: Platelet-derived growth factor, Negative: No progression, Positive: Progression